comparemela.com

Latest Breaking News On - Cade cadx - Page 4 : comparemela.com

Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device - Press Release

Median has received the FDA's feedback following the 513(g) regulatory submission for its iBiopsy® LCS CADe/CADx Software as Medical Device. Median wi

United statesFrance generalCade cadxLcs cade cadxRadiological computer assisted detection and diagnosis softwareCade cadx software as medical deviceSoftware as medical device saAi software as medical deviceDrug administrationLcs cade cadx software as medical deviceUnited states foodLung cancer screeningMedical deviceMedian technologiesFredrik bragArtificial intelligence

Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022

Record high revenue of €5.7 million in Q1 2022, up 9.2% compared with Q1 2021 Further growth in the order backlog to €62.3 million as of March 31, 2022, up 18.4% compared with March 31, 2021

United statesFrance generalEmmanuelle leyguesCade cadxLcs cade cadxGhislaine gasparettoCaroline carmagnolHead of corporate marketing financial communicationsImaging contract research organizationRadiological society of north americaBiopsy lung cancer screeningEuronext growthMedian technologiesFredrik bragAnnual meetingRadiological society

Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device

Median Technologies files FDA 513(g) regulatory submission for iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device  ·      513(g) submission is a key milestone that marks the initiation of Median’s interactions with the FDA.·  &nbsp.

United statesFrance generalCade cadxLcs cade cadxSoftware as medical device saAi software as medical deviceDrug administrationLcs cade cadx software as medical deviceMedian technologiesLung cancer screeningUnited states foodMedical deviceFredrik bragArtificial intelligenceData scienceEuronext growth

Median Technologies Files FDA 513(g) Regulatory Submission for iBiopsy Lung Cancer Screening CADe/CADx Software as Medical Device

iBiopsy LCS CADe/CADx SaMD could significantly contribute to eliminating barriers to the widespread adoption of lung cancer screening programs and save the lives of millions of patients

United statesCade cadxCade cadx software as medical device saDrug administrationMedian technologiesUnited states foodBiopsy lung cancer screeningMedical deviceFredrik brag

GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and Localize Fractures

/PRNewswire/ GLEAMER, a French medtech company pioneering the use of artificial intelligence technology in the practice of radiology, announced today that.

United statesBoston universityFrance generalCade cadxVivy cohenChristian alloucheAli guermaziIvy cohen corporate communicationsDrug administrationBoston university school of medicineHarvard medical schoolFerrum healthStony brook university renaissance school of medicineUnited states foodBoston university schoolEuropean union

vimarsana © 2020. All Rights Reserved.